跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
莊 國祥
教授
,
生藥學研究所
合聘教授
,
轉譯醫學博士學位學程
合聘教授
,
新藥研發產業博士學位學程
合聘教授
,
中草藥臨床藥物研發博士學位學程
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
成員
,
臺北醫學大學新藥開發研究中心
成員
,
臺北醫學大學癌症轉譯研究中心
成員
,
臺北醫學大學細胞治療與再生醫學研究中心
https://orcid.org/0000-0001-7513-2671
電子郵件
khchuang
tmu.edu
tw
h-index
1574
引文
23
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2025
每年研究成果
概覽
指紋
網路
專案
(37)
研究成果
(66)
資料集
(6)
類似的個人檔案
(6)
指紋
查看啟用 Kuo-Hsiang Chuang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Macrogol
91%
Malignant Neoplasm
57%
Beta Glucuronidase
43%
Nanoparticle
43%
Polyethylene Glycol
37%
Bispecific Antibody
33%
Nanocarrier
29%
Enzyme-Linked Immunosorbent Assay
26%
Mouse
25%
Epidermal Growth Factor Receptor
24%
Glucuronide
24%
Epidermal Growth Factor Receptor 2
22%
Histone Deacetylase 6
21%
Docetaxel
21%
Gamma Urogastrone
21%
Combination Therapy
20%
Drug Development
17%
Prodrug
17%
Hydroxamic Acid
16%
Nanomedicine
16%
Pharmacokinetics
15%
Biological Activity
15%
Monoclonal Antibody
15%
Fluorescent Dye
15%
IC50
14%
Solid Malignant Neoplasm
14%
Anilide
14%
Lung Cancer
14%
Pharmaceutical Chemistry
14%
Virtual Screening
14%
Triple Negative Breast Cancer
14%
4,4' Isopropylidenediphenol
14%
Connexin 43
14%
Cytokine
13%
Liposome
13%
Escherichia coli
13%
Fluorescein
12%
Heat Shock Protein 90
12%
Cytotoxicity
11%
Programmed Death 1 Ligand 1
10%
Mouse Model
10%
Breast Cancer
10%
Immunogenicity
9%
Doxorubicin
9%
ELISA Sandwich
8%
Egg Lecithin
8%
Anticarcinogen
8%
Tumor Microenvironment
8%
Kudzu
7%
Immunology and Microbiology
Monospecific Antibody
71%
Mouse
29%
ELISA
25%
ELISA Sandwich
24%
Monoclonal Antibody
23%
Reporter Gene
19%
Gene Expression
19%
Bispecific Antibody
18%
Enzyme-Linked Immunosorbent Assay
18%
Pharmacokinetics
17%
Peginterferon Alfa-2a
15%
Immunogenicity
15%
Immunoassay
14%
Immunoglobulin M
13%
Cancer Cell
13%
Surface Property
11%
Tumor Necrosis Factor
11%
Tumor Cell
10%
T Cell
9%
Immunoglobulin M Antibody
9%
Carcinoma Cell
9%
Glycosylation
9%
Immune Response
8%
Epidermal Growth Factor
8%
Pegylated Interferon
8%
Inflammatory Arthritis
8%
Binding Affinity
8%
Infliximab
7%
Interferon Type I
7%
V(D)J Recombination
7%
CEACAM6
7%
Immunoglobulin G Antibody
7%
Mesenchymal Stem Cell
7%
Squamous Cell
7%
Classical Swine Fever Virus
7%
Immunosuppressive Drug
7%
Gamma Urogastrone
7%
Intestine
7%
Octamer Transcription Factor 4
7%
Computer Model
7%
Growth Factor
7%
Germinal Center
7%
Cancer Stem Cell
7%
Hybridoma
7%
Tumor Necrosis Factor Receptor
7%
Interleukin 33
7%
VCAM-1
7%
Tumor Necrosis Factor Receptor Superfamily Member 9
7%
Urelumab
7%
Western Blot
6%
Medicine and Dentistry
Neoplasm
40%
Nanoparticle
31%
Glucuronide
23%
Beta Glucuronidase
23%
Diethylstilbestrol
21%
Bispecific Antibody
18%
Malignant Neoplasm
16%
Macrogol
15%
Mesenchymal Stem Cell
14%
Cancer Stem Cell
14%
Multimodality Imaging
14%
Granulosa Cell
14%
Bisphenol A
14%
Connexin 43
14%
In Vitro
12%
Gene Expression
11%
Endocytosis
9%
Endometrium Tumor
9%
Receptor
9%
Tumor Cell
8%
Cancer Cell
8%
Mitogen-Activated Protein Kinase
8%
T Cell
8%
Prodrug
8%
Cancer Therapy
8%
Gelatinase B
8%
Endometrium
8%
Cell Proliferation
8%
Carcinoma Cell
8%
Combination Therapy
8%
Fluorescent Dye
7%
Breast Cancer
7%
Epidermal Growth Factor Receptor 2
7%
Cell Communication
7%
down Regulation
7%
Endometriosis
7%
Gamma Urogastrone
7%
Protein G
7%
Polyprotein
7%
Stromal Cell
7%
Fluorescein
7%
Immunoassay
7%
Octamer Transcription Factor 4
7%
Cisplatin
7%
Endometrium Carcinoma
7%
Interleukin 33
7%
Tumor Necrosis Factor Receptor
7%
Histone Deacetylase 6
7%
Genetic Engineering
7%
Hapten
7%
